Q2 2019
Released Aug 1, 2019, after the close
10-Q filed Aug 1, 2019, 32 days after period end · 0001237831-19-000042
Q2 2019 · 10-Q
Revenue$194.54M$194.54M +12.2% vs Q2 2018−0.7% vs Q4 2018
Net Income$38.16M$38.16M −15.1% vs Q2 2018+3.8% vs Q4 2018
EPS Diluted$0.38$0.38 −13.6% vs Q2 2018+5.6% vs Q4 2018
Gross Profit$150,549,000+10.9%
Operating Income$42,869,000+1.7%
Operating Cash Flowderived$22,597,000−32.1%
Free Cash Flowderived$7,857,000−57.5%
Margins · derived
Gross margin77.4%−0.9 pt vs Q2 2018
Operating margin22.0%−2.3 pt vs Q2 2018
Net margin19.6%−6.3 pt vs Q2 2018
What the release said
The release
Same quarter
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Revenue | $194.54M | $173.38M | $152.39M | $137.49M |
| Net Income | $38.16M | $44.98M | $28.67M | $25.81M |
| EPS Diluted | $0.38 | $0.44 | $0.29 | $0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Globus Medical Inc · CIK 1237831 · Engraved from SEC EDGAR